Literature DB >> 27440100

SPIRIT 2013 Statement: defining standard protocol items for clinical trials.

An-Wen Chan1, Jennifer M Tetzlaff2, Douglas G Altman3, Andreas Laupacis4, Peter C Gøtzsche5, Karmela Krle A-Jerić6, Asbjørn Hrobjartsson5, Howard Mann7, Kay Dickersin8, Jesse A Berlin9, Caroline J Dore10, Wendy R Parulekar11, William S M Summerskill12, Trish Groves13, Kenneth F Schulz14, Harold C Sox15, Frank W Rockhold14, Drummond Rennie16, David Moher17.   

Abstract

The protocol of a clinical trial serves as the foundation for study planning, conduct, reporting, and appraisal. However, trial protocols and existing protocol guidelines vary greatly in content and quality. This article describes the systematic development and scope of SPIRIT (Standard Protocol Items: Recommendations for Interventional Trials) 2013, a guideline for the minimum content of a clinical trial protocol. The 33-item SPIRIT checklist applies to protocols for all clinical trials and focuses on content rather than format. The checklist recommends a full description of what is planned; it does not prescribe how to design or conduct a trial. By providing guidance for key content, the SPIRIT recommendations aim to facilitate the drafting of high-quality protocols. Adherence to SPIRIT would also enhance the transparency and completeness of trial protocols for the benefit of investigators, trial participants, patients, sponsors, funders, research ethics committees or institutional review boards, peer reviewers, journals, trial registries, policymakers, regulators, and other key stakeholders.

Entities:  

Mesh:

Year:  2015        PMID: 27440100      PMCID: PMC5114122     

Source DB:  PubMed          Journal:  Rev Panam Salud Publica        ISSN: 1020-4989


  39 in total

1.  The power of the protocol.

Authors:  Marissa Lassere; Kent Johnson
Journal:  Lancet       Date:  2002-11-23       Impact factor: 79.321

2.  Empirical evidence for selective reporting of outcomes in randomized trials: comparison of protocols to published articles.

Authors:  An-Wen Chan; Asbjørn Hróbjartsson; Mette T Haahr; Peter C Gøtzsche; Douglas G Altman
Journal:  JAMA       Date:  2004-05-26       Impact factor: 56.272

Review 3.  Principles for international registration of protocol information and results from human trials of health related interventions: Ottawa statement (part 1).

Authors:  Karmela Krleza-Jerić; An-Wen Chan; Kay Dickersin; Ida Sim; Jeremy Grimshaw; Christian Gluud
Journal:  BMJ       Date:  2005-04-23

Review 4.  Subgroup analysis and covariate adjustment in randomized clinical trials of traumatic brain injury: a systematic review.

Authors:  Adrían V Hernández; Ewout W Steyerberg; Gillian S Taylor; Anthony Marmarou; J Dik F Habbema; Andrew I R Maas
Journal:  Neurosurgery       Date:  2005-12       Impact factor: 4.654

5.  Clinical trial registration: looking back and moving ahead.

Authors:  Christine Laine; Catherine De Angelis; Tony Delamothe; Jeffrey M Drazen; Frank A Frizelle; Charlotte Haug; Paul C Hébert; Richard Horton; Sheldon Kotzin; Ana Marusic; Peush Sahni; Torben V Schroeder; Harold C Sox; Martin B Van der Weyden; Freek W A Verheugt
Journal:  Ann Intern Med       Date:  2007-06-04       Impact factor: 25.391

6.  Access to clinical trial data.

Authors:  An-Wen Chan
Journal:  BMJ       Date:  2011-01-12

7.  SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials.

Authors:  An-Wen Chan; Jennifer M Tetzlaff; Peter C Gøtzsche; Douglas G Altman; Howard Mann; Jesse A Berlin; Kay Dickersin; Asbjørn Hróbjartsson; Kenneth F Schulz; Wendy R Parulekar; Karmela Krleza-Jeric; Andreas Laupacis; David Moher
Journal:  BMJ       Date:  2013-01-08

8.  Comparison of protocols and registry entries to published reports for randomised controlled trials.

Authors:  Kerry Dwan; Douglas G Altman; Lynne Cresswell; Michaela Blundell; Carrol L Gamble; Paula R Williamson
Journal:  Cochrane Database Syst Rev       Date:  2011-01-19

9.  Frequency and reasons for outcome reporting bias in clinical trials: interviews with trialists.

Authors:  R M D Smyth; J J Kirkham; A Jacoby; D G Altman; C Gamble; P R Williamson
Journal:  BMJ       Date:  2011-01-06

10.  Guidelines for randomized clinical trial protocol content: a systematic review.

Authors:  Jennifer M Tetzlaff; An-Wen Chan; Jessica Kitchen; Margaret Sampson; Andrea C Tricco; David Moher
Journal:  Syst Rev       Date:  2012-09-24
View more
  99 in total

1.  Setting the agenda: an informatics-led policy framework for adaptive CDS.

Authors:  Jeffery Smith
Journal:  J Am Med Inform Assoc       Date:  2020-12-09       Impact factor: 4.497

2. 

Authors:  Judy King; Lucie Brosseau; Paulette Guitard; Chantal Laroche; Julie Alexandra Barette; Dominique Cardinal; Sabrina Cavallo; Lucie Laferrière; Karine Toupin-April; Marie-Ève Bérubé; Jennifer O'Neil; Jessane Castro; Cendy Kidjo; Sandy Fakhry; Ann Sutton; Roseline Galipeau; Jocelyne Tourigny; Josée Lagacé; Catrine Demers; Nicole Paquet; Denyse Pharand; Laurianne Loew; Véronique Vaillancourt; Katrine Sauvé-Schenk
Journal:  Physiother Can       Date:  2019       Impact factor: 1.037

3.  Dry needling in addition to standard physical therapy treatment for sub-acromial pain syndrome: a randomized controlled trial protocol.

Authors:  Ben R Hando; Daniel I Rhon; Joshua A Cleland; Suzanne J Snodgrass
Journal:  Braz J Phys Ther       Date:  2018-11-06       Impact factor: 3.377

4.  Evaluation of Safety and Efficacy of ReHub in Patients Who Underwent Primary Total Knee Arthroplasty: Study Protocol for a Randomized Controlled Trial.

Authors:  Montse Nuevo; Hadis Mahdavi; Daniel Rodríguez; Teresa Faura; Núria Fabrellas; Simone Balocco; Marco Conti; Alessandro Castagna; Salvi Prat
Journal:  Int J Surg Protoc       Date:  2021-04-19

5.  Stepped care approach for medial tibiofemoral osteoarthritis (STrEAMline): protocol for a randomised controlled trial.

Authors:  Sarah Rubia Robbins; Luciano Ricardo S Melo; Hema Urban; Leticia A Deveza; Rebecca Asher; Victoria L Johnson; David J Hunter
Journal:  BMJ Open       Date:  2017-12-26       Impact factor: 2.692

6.  Efficacy and safety of Xiangsha Liujunzi granules for functional dyspepsia: A multi-center randomized double-blind placebo-controlled clinical study.

Authors:  Lin Lv; Feng-Yun Wang; Xiang-Xue Ma; Zhen-Hua Li; Sui-Ping Huang; Zhao-Hong Shi; Hai-Jie Ji; Li-Qun Bian; Bei-Hua Zhang; Ting Chen; Xiao-Lan Yin; Xu-Dong Tang
Journal:  World J Gastroenterol       Date:  2017-08-14       Impact factor: 5.742

7.  A study protocol for a multicentre randomised clinical trial evaluating the safety and feasibility of a bioengineered human allogeneic nanostructured anterior cornea in patients with advanced corneal trophic ulcers refractory to conventional treatment.

Authors:  Miguel González-Andrades; Rosario Mata; María Del Carmen González-Gallardo; Santiago Medialdea; Salvador Arias-Santiago; Juliana Martínez-Atienza; Antonio Ruiz-García; Lorena Pérez-Fajardo; Antonio Lizana-Moreno; Ingrid Garzón; Antonio Campos; Miguel Alaminos; Gloria Carmona; Natividad Cuende
Journal:  BMJ Open       Date:  2017-09-24       Impact factor: 2.692

Review 8.  Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users.

Authors:  Lone Baandrup; Bjørn H Ebdrup; Jesper Ø Rasmussen; Jane Lindschou; Christian Gluud; Birte Y Glenthøj
Journal:  Cochrane Database Syst Rev       Date:  2018-03-15

9.  A Peer-Led Electronic Mental Health Recovery App in an Adult Mental Health Service: Study Protocol for a Pilot Trial.

Authors:  Amelia Gulliver; Michelle Banfield; Julia Reynolds; Sarah Miller; Connie Galati; Alyssa R Morse
Journal:  JMIR Res Protoc       Date:  2017-12-07

10.  Study protocol: A multi-centre, double blind, randomised, placebo-controlled, parallel group, phase II trial (RIDD) to determine the efficacy of intra-nodular injection of anti-TNF to control disease progression in early Dupuytren's disease, with an embedded dose response study.

Authors:  Jagdeep Nanchahal; Catherine Ball; Jennifer Swettenham; Susan Dutton; Vicki Barber; Joanna Black; Bethan Copsey; Melina Dritsaki; Peter Taylor; Alastair Gray; Marc Feldmann; Sarah Lamb
Journal:  Wellcome Open Res       Date:  2017-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.